Percutaneous coronary intervention and adjunctive pharmacotherapy in women - A statement for healthcare professionals from the American Heart Association

被引：178

作者：

Lansky, AJ

Hochman, JS

Ward, PA

Mintz, GS

Fabunmi, R

Berger, PB

New, G

Grines, CL

Pietras, CG

Kern, MJ

Ferrell, M

Leon, MB

Mehran, R

White, C

Mieres, JH

Moses, JW

Stone, GW

Jacobs, AK

机构：

来源：

CIRCULATION | 2005年 / 111卷 / 07期

关键词：

AHA Scientific Statements; women; coronary disease; pharmacology; catheterization; angioplasty;

D O I：

10.1161/01.CIR.0000155337.50423.C9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

More than 1.2 million percutaneous coronary interventions are performed annually in the United States, with only an estimated 33% performed in women, despite the established benefits of percutaneous coronary intervention and adjunctive pharmacotherapy in reducing fatal and nonfatal ischemic complications in acute myocardial infarction and high-risk acute coronary syndromes. This statement reviews sex-specific data on the safety and efficacy of contemporary interventional therapies in women.

引用

页码：940 / 953

页数：14

共 141 条

[71] New-device angioplasty in women: Clinical outcome and predictors in a 7,372-patient registry [J].

Lansky, AJ ;

Mehran, R ;

Dangas, G ;

Desai, K ;

Costantini-Ortiz, C ;

Cristea, E ;

New, G ;

Negoita, M ;

Stone, GW ;

Leon, MB .

EPIDEMIOLOGY, 2002, 13 (03) :S46-S51

[72]

LANSKY AJ, IN PRESS J AM COLL C

[73]

LANSKY AJ, IN PRESS CIRCULATION

[74] Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction [J].

Lefkovits, J ;

Ivanhoe, RJ ;

Califf, RM ;

Bergelson, BA ;

Anderson, KM ;

Stoner, GL ;

Weisman, HF ;

Topol, EJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (12) :1045-1051

[75] A clinical trial comparing three antithrombotic drug regimens after coronary-artery stenting [J].

Leon, MB ;

Baim, DS ;

Popma, JJ ;

Gordon, PC ;

Cutlip, DE ;

Ho, KKL ;

Giambartolome, A ;

Diver, DJ ;

Lasorda, DM ;

Williams, DO ;

Pocock, SJ ;

Kuntz, RE .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (23) :1665-1671

[76] Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab - One-year outcome in the EPILOG trial [J].

Lincoff, AM ;

Tcheng, JE ;

Califf, RM ;

Kereiakes, DJ ;

Kelly, TA ;

Timmis, GC ;

Kleiman, NS ;

Booth, JE ;

Balog, C ;

Cabot, CF ;

Anderson, KM ;

Weisman, HF ;

Topol, EJ .

CIRCULATION, 1999, 99 (15) :1951-1958

[77] Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization - REPLACE-2 randomized trial [J].

Lincoff, AM ;

Kleiman, NS ;

Kereiakes, DJ ;

Feit, F ;

Bittl, JA ;

Jackman, JD ;

Sarembock, IJ ;

Cohen, DJ ;

Spriggs, D ;

Ebrahimi, R ;

Keren, G ;

Carr, J ;

Cohen, EA ;

Betriu, A ;

Desmet, W ;

Rutsch, W ;

Wilcox, RG ;

de Feyter, PJ ;

Vahanian, A ;

Topol, EJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (06) :696-703

[78] Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention - REPLACE-2 Randomized Trial [J].

Lincoff, AM ;

Bittl, JA ;

Harrington, RA ;

Feit, F ;

Kleiman, NS ;

Jackman, JD ;

Sarembock, IJ ;

Cohen, DJ ;

Spriggs, D ;

Ebrahimi, R ;

Keren, G ;

Carr, J ;

Cohen, EA ;

Betriu, A ;

Desmet, W ;

Kereiakes, DJ ;

Rutsch, W ;

Wilcox, RG ;

de Feyter, PJ ;

Vahanian, A ;

Topol, EJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (07) :853-863

[79] Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization [J].

Lincoff, AM ;

Tcheng, JE ;

Califf, RM ;

Bass, T ;

Popma, JJ ;

Teirstein, PS ;

Kleiman, NS ;

Hattel, LJ ;

Anderson, HV ;

Ferguson, JJ ;

Cabot, CF ;

Anderson, KM ;

Berdan, LG ;

Musco, MH ;

Weisman, HF ;

Topol, EJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (03) :286-291

[80] Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors [J].

Lincoff, AM ;

Califf, RM ;

Moliterno, DJ ;

Ellis, SG ;

Ducas, J ;

Kramer, JH ;

Kleiman, NS ;

Cohen, EA ;

Booth, JE ;

Sapp, SK ;

Cabot, CF ;

Topol, EJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :319-327

← 3 4 5 6 7 8 9 10 11 12 →